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Abstract 
 
Lymantria dispar (Ld652) cells are normally resistant to infection by vesicular stomatitis virus 
(VSV), a simple RNA virus.  However, when co-infected with vaccinia virus (VACV), a 
poxvirus used as a vaccine for smallpox, VSV is able to productively infect these cells.  Previous 
work has shown that the sole factor responsible for this rescue of VSV by VACV is a highly 
conserved poxvirus protein known as A51, but the mechanism of this rescue is not currently 
understood.  The mechanism behind this rescue was investigated using a yeast two-hybrid 
system to identify potential A51-binding proteins.  A cDNA library was created from Ld652 
cells, and the library was screened using A51 as bait.  The same two-hybrid technology was used 
to screen A51 against a mouse cDNA library, and against itself to test for self-interaction.  The 
data indicate that A51 self-interaction is not sufficient for the rescue process. 
 
 
  
 3 
 
 
Table of Contents 
Abstract ........................................................................................................................................... 2 
Table of Contents ........................................................................... Error! Bookmark not defined. 
Acknowledgements ......................................................................................................................... 4 
Background ..................................................................................................................................... 5 
Project Purpose ............................................................................................................................. 13 
Materials and Methods .................................................................................................................. 14 
Results ........................................................................................................................................... 23 
Discussion ..................................................................................................................................... 27 
References ..................................................................................................................................... 29 
 
 
 
  
 4 
Acknowledgements 
 
 
 I would like to thank my major advisor, Dr. Craig Mello for allowing me to perform this 
research in his lab.  I would also like thank Dr. Don Gammon for working closely with me in the 
lab and providing invaluable assistance and guidance throughout the entirety of this project.  His 
knowledge and patience were a great attribute to my research.  I appreciate the efforts of 
everyone in the Mello lab who helped me work though new protocols.  Finally, I would like to 
thank my WPI advisors, Dr. Destin Heilman and Dr. David Adams for their advice and guidance 
during this project. 
  
 5 
Background 
 
Poxviridae Genome 
 
Poxviridae is a family of 13 different, linear, double-stranded DNA viruses that is split 
into two subfamilies: Chordopoxvirinae, which consists of poxviruses that infect vertebrates, and 
Entomopoxviridae, which infect insects.  Poxviruses have significantly affected our history, 
especially variola virus, the causative agent of smallpox, which, prior to being eradicated in 
1980, had killed more humans than all other infectious diseases combined over the course of 
recorded history (McFadden, 2005).  For this reason, it is important that we understand the 
Poxviridae family, and how they cause disease. 
Understanding poxviruses is particularly challenging given the sheer size of their 
genome.  Many of the common viruses affecting the world today have relatively small genomes; 
influenza virus contains 8 genes encoding 11 proteins (Clancy, 2008).  The second largest virus 
family, Herpesviridae, which infects the majority of the world’s adult population, contains 
approximately 85 different genes (Amon and Farrell, 2005).  These genomes are miniscule 
however, when compared to that of vaccinia virus (VACV), which has been used as a vaccine for 
smallpox, which contains over 263 genes (Yang et al., 2010). 
While evolution has pushed many viruses towards smaller genomes in the pursuit of 
quicker replication, poxviruses have somehow retained their large genomes.  Over 90 open 
reading frames are conserved among the entire poxvirus family (McFadden, 2005), indicating 
extremely powerful and utile gene functions.  Poxviruses function in very intricate ways during 
infection.  As DNA viruses, they have unique patterns of temporal gene expression, consisting of 
early, intermediate, and late stage genes.  This enables them to carefully time their life cycle so 
that resources are not wasted on unnecessary processes.  They also encode their own DNA and 
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RNA polymerases, which is very different from other double-stranded DNA viruses.  This 
allows poxviruses to replicate their genome in the cytoplasm using their own machinery, while 
most double-stranded DNA viruses must enter the nucleus of the infected cell and hijack the host 
cellular machinery for gene expression and replication. 
Despite smallpox being declared eradicated by the World Health Organization in 1980, 
Poxviridae remain an important area of virology research.  Other types of poxviruses still 
remain, affecting organisms from moths to camels to monkeys, and an evolutionary leap from 
one of these hosts to humans is not unheard of.  For example, in 2003 a monkeypox outbreak in 
the United States, originating from imported Gambian pouched rats, infected 71 people in the 
Midwest (CDC, 2003).  Even greater is the threat of bioterrorism – during the cold war, the 
Soviet government funded a successful project to produce large quantities of the variola virus 
and use it in weapons (Henderson et al., 1999).  Clearly poxviruses remain a very real threat, and 
in order to combat them, we must understand how they replicate and cause disease.  This is no 
easy task, given the massive genome and intricate infection mechanisms.  Understanding how 
these viruses function and how they are able to successfully infect a host, evade the immune 
system, and shut down myriad different cellular responses will improve our understanding of 
how to treat viral infection. 
 
Poxviridae Infection Mechanisms 
 
 Poxviruses owe a large part of their pathogenic success to their highly conserved 
replication cycle.  This cycle has been best studied in VACV, but as many proteins are conserved 
in both structure and function throughout the Poxviridae family, it is thought that the cycle likely 
is similar among other members. 
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Figure 1: Poxvirus Life Cycle (McFadden, 2005) 
The Intracellular Mature Virus (IMV) or Extracellular Enveloped Virus (EEV) attach to the cell membrane of the 
target cell.  Upon entering the cell, the virion is uncoated and early gene expression begins.  DNA is also replicated 
during this time.  Upon reaching a certain level of viral DNA replication, intermediate gene expression begins.  
Finally, late gene expression begins and viral assembly occurs.  IMVs receive a membrane from the Golgi and exit 
the cell via exocytosis. 
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The process begins with either the Intracellular Mature Virus (IMV) or Extracellular 
Enveloped Virus (EEV) attaching to the cell membrane of the target cell as shown in Figure 1.  
These two viral particles differ in their surface proteins and the number of membranes they have, 
but their DNA is identical.  The method of entry of the two different particles is thought to be 
different and is not fully understood.  It is known that surface proteins on the particles attach to 
the surface of the target cell, and the virions enter by fusing their membrane with the cell 
membrane, thus releasing the virion core into the cytoplasm (McFadden, 2005).   
 As the core is uncoated to release the viral DNA, early transcription begins within 
minutes of entering the cell, using the viral DNA-dependent RNA polymerase as well as viral 
methylation and polyadenylation enzymes, which are packaged within the core (Broyles, 2003).  
This allows the transcription and processing of early genes, using the host ribosomes for 
translation.  These early genes consist largely of factors that promote viral growth, replication 
machinery, and cytokine inhibitors to prevent host immune functions.  This serves not only to 
protect the virus as it begins to replicate, but to ensure that hijacked cellular machinery and 
resources are devoted to viral replication rather than normal cell growth. 
 A viral encoded DNA-dependent DNA polymerase is also synthesized during this early 
phase, allowing DNA replication to begin, providing more copies of the poxvirus genome for 
gene transcription.  Not being dependent on the host DNA or RNA polymerases allows 
poxviruses to replicate within the cytoplasm, where viral “factories” begin to form, localizing all 
of the viral and cellular machinery needed for production of more viruses into specific spots 
within the cell. 
 After the virion uncoating process has been completed and the virus has begun to 
replicate its DNA, intermediate genes are expressed using the same machinery as early genes.  
These intermediate genes consist mainly of factors that block host immune responses, including 
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apoptosis inhibitors, host-range proteins, antiviral state inhibitors, and signaling modulators 
(McFadden, 2005).  All of these factors serve to prevent the host from properly responding to the 
virus. Different poxviruses contain different host-range genes, which are specific to the 
organisms they are adapted to. 
 Finally, synthesis of new RNA polymerase molecules leads to late gene transcription.  At 
this point in the viral life cycle, the majority of host cell transcription has been shut down, which 
serves to impede the host response to infection.  Late genes generally encode proteins required 
for viral assembly, such as structural proteins, envelope proteins, and the proteins packaged 
within the viral particles.  At this point, IMVs are created, some of which then use the golgi body 
of the host cell to obtain an outer membrane to become EEVs.  These EEVs then travel to the 
surface of the cell using the host cell cytoskeleton where they are released into the extracellular 
environment (Schepis et al., 2006).  IMVs are also released from the cell upon rupture as a result 
of infection.  Either virus particle is then capable of infecting a new host cell and restarting the 
cycle. 
 Many of the elements of this pathway are not fully understood, yet it can clearly be seen 
why poxviruses are such successful pathogens.  By properly timing their gene expression, and 
encoding a wide range of factors that reduce dependence on cell machinery as well as prevent 
host responses, poxviruses are able to successfully replicate within their target hosts. 
 
Vesicular Stomatitis Virus 
Vesicular Stomatitis Virus (VSV) is a negative-sense RNA virus, meaning its genome 
consists of a single strand of RNA which cannot be directly translated, but requires the 
production of positive-sense viral mRNAs (using the genome as a template).  These positive-
sense mRNAs are then translated into individual proteins by host ribosomes.  It is a member of 
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the Rhabdoviridae family of rod-shaped, negative-sense, single-stranded RNA viruses that 
generally contain genes for five different proteins: L (the viral RNA polymerase), G (the surface 
glycoprotein) and M (the matrix protein), P (the phosphoprotein) and N (the nucleoprotein).  
VSV naturally infects rodents, cattle, swine and horses, and is thought to be spread between 
species via insects (Lichty et al., 2004). 
VSV infection lacks many of the intricacies of the poxvirus life cycle, but this is to be 
expected, given its relatively small genome.  VSV first binds to receptors on the cell surface, and 
is taken in via endocytosis, initiated by the G protein.  Once inside the cell, a change in pH 
conditions within the endocytic vesicle triggers fusion of the VSV membrane to the vesicle, 
releasing the viral RNA into the cytoplasm of the cell.  The viral RNA polymerase then 
transcribes the mRNA from each of the VSV genes, which are subsequently translated using host 
cell machinery (Poch et al., 1990).  This RNA synthesis continues until the viral RNA 
polymerase switches from a transcription function to a replication function by a mechanism 
involving the phosphoprotein (Ribeiro et al., 2008), and begins producing copies of the negative-
sense genome using positive-sense intermediate RNA strands (Lichty et al., 2004).  The negative 
sense viral RNA produced in this step is encapsidated by the nucleoprotein, signaling that the 
virion is ready for assembly (Assenberg et al., 2010).  The necessary viral structural proteins are 
then assembled in the cytoplasm, and G protein is used to obtain a membrane and facilitate exit 
from the cell via budding. 
 VSV M protein is thought to serve a variety of roles such as interferon inhibition and 
viral budding (Ferran and Lucas-Lenard, 1997).  Experiments have demonstrated that VSV-
infected cells produce little, if any, interferon response.  This is a significant antiviral pathway, 
and the M protein has been shown to inhibit it through blockage of host RNA and protein 
synthesis, effectively shutting down the cellular response to infection (Ahmed et al., 2003).  
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Additionally, the M protein contains motifs similar to those found in retroviral proteins that 
function in viral budding.  Analysis of this domain has led to the conclusion that the M protein 
may be responsible for causing the budding that allows newly synthesized VSV particles to 
obtain a membrane and leave the host cell (Craven et al., 1999). 
 
Preliminary Experiments and Vaccinia Protein A51 
Most cell lines are permissive to VSV infection, but Ld652 cells, a line of Lymantria 
dispar gypsy moth cells, are not (Gammon and Mello, unpublished data).  Ld652 are also non-
permissive to VACV infection, however this is a late stage abortive infection, meaning all genes 
are expressed but the infection fails just prior to virion assembly (Li and Moyer, 1998).  Through 
experimentation in our lab, it was found that Ld652 cells infected with VACV are permissive to 
VSV infection, suggesting that VACV is capable of “rescuing” VSV (Gammon and Mello, 
unpublished data). 
In order to identify the VACV factor(s) responsible for this rescue phenotype, an RNA 
interference (RNAi) screen was performed by members of our lab, targeting several VACV 
genes with unknown functions.  The results showed that only the knockdown of transcripts 
encoding the VACV gene A51R prevented VACV-mediated rescue of VSV (Gammon and 
Mello, unpublished data).   
 A51R encodes a highly conserved poxvirus protein (termed A51), found in nearly every 
member of the Poxviridae family.  It is expressed both early and late in infection (Gammon and 
Mello, unpublished data).  Interestingly, VACV A51 is able to promote VSV replication in 
Ld652 cells in the absence of other poxvirus proteins, suggesting that the rescue phenotype is the 
result of A51 interacting with host proteins rather than other viral proteins. 
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 When comparing the sequences of A51 genes across the poxvirus family, we determined 
that the sequence is highly conserved within the last 30 residues.  Interestingly, the A51 protein 
encoded by Modified Vaccinia Ankara (MVA) virus, a modified strain of VACV, is truncated by 
25 residues at the C-terminal end.  These missing residues are replaced by 5 different residues as 
shown in Figure 2.  The MVA strain was unable to rescue VSV (Gammon and Mello, 
unpublished data), confirming that these last few residues were essential for the rescue provided 
by A51. 
VAC VA51         MDGVIVYCLNALVKHGEEINHIKNDFMIKPCCERVCEKVKNVHIGGQSKNNTVIADLPYM 
MVA A51          MDGVIVYCLNALVKHGEEINHIKNDFMIKPCCE----KVKNVHIGGQSKNNTVIADLPYM 
                 *********************************    *********************** 
 
VAC VA51         DNAVSDVCNSLYKKNVSRISRFANLIKIDDDDKTPTGVYNYFKPKDVIPVIISIGKDKDV 
MVA A51          DNAVSDVCNSLYKKNVSRISRFANLIKIDDDDKTPTGVYNYFKPKDAIPVIISIGKDRDV 
                 **********************************************.**********:** 
 
VACV A51         CELLISSDISCACVELNSYHVAILPMDVSFFTKGNASLIILLFDFSIDAAPLLRSVTDNN 
MVA A51          CELLISSDKACACIELNSYKVAILPMDVSFFTKGNASLIILLFDFSIDAAPLLRSVTDNN 
                 ******** :***:*****:**************************************** 
 
VACV A51         VIISRHQRLHDELPSSNWFKFYISIKSDYCSILYMVVDGSVMHAIADNRTHAIISKNILD 
MVA A51          VIISRHQRLHDELPSSNWFKFYISIKSDYCSILYMVVDGSVMHAIADNRTYANISKNILD 
                 **************************************************:* ******* 
 
VACV A51         NTTINDECRCCYFEPQIRILDRDEMLNGSSCDMNRHCIMMNLPDVGKFGSSMLGKYEPDM 
MVA A51          NTTINDECRCCYFEPQIRILDRDEMLNGSSCDMNRHCIMMNLPDVGEFGSSMLGKYEPDM 
                 **********************************************:************* 
 
VACV A51         IKIALSVAGNLIRNRDYIPGRRGYSYYVYGIASR 
MVA A51          IKIALSVAGIWKVL-------------------- 
                 *********                          
 
Figure 2: VACV vs. MVA A51 Sequence 
The VACV (top) and MVA (middle) A51 amino acid sequences were compared using the CLUSTALW program.  
The sequence is largely conserved, with the major difference being the C-terminal truncation of the A51 form. 
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Project Purpose 
 
Our lab previously showed that VACV protein A51 can rescue VSV by allowing it to 
infect Ld652 insect cells (Gammon and Mello, unpublished data).  Other than this unpublished 
work, very little is known about A51.  A previous yeast two-hybrid study found A51 to interact 
with itself and VACV E8R (McCraith et al., 2000), a protein implicated in viral transcription 
(Kato et al., 2007).  Bioinformatics have failed to provide any discernible motifs or domains 
within the A51 amino acid sequence and thus its function is largely unknown. 
 This project investigated the use of the yeast two-hybrid system to identify potential A51-
binding proteins in host cells.  We tested both VACV A51 and the mutant MVA form for 
binding partners.  This approach may help determine which protein interactions are necessary for 
the observed rescue activity by A51.  These two-hybrid screens were performed against a cDNA 
library created from Ld652 cells.  Additionally, A51 was screened against a standardized mouse 
library to explore potential protein interactions in a mammalian host.  The results from this 
screen will provide a picture of the proteins which A51 interacts with, thus giving clues to its 
function within poxviruses, and how it is able to rescue VSV.   Additionally, A51 was screened 
against itself and against MVA to determine whether A51 self-interaction is important for the 
observed VSV rescue. 
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Materials and Methods 
 
cDNA Library Creation 
RNA Preparation  
A cDNA library was created from approximately 9 x 10
6
 uninfected Ld652 cells.  Cells 
were taken from a stock culture and diluted 10-fold into two wells of a 24-well dish.  The wells 
were grown to confluence, and total cellular RNA was isolated using the Clontech NucleoSpin 
RNA XS kit (cat no. 740902).  Briefly, cells were lysed and extracts were passed through a silica 
membrane by centrifugation at 8,000 g for 30 seconds to bind the RNA to the column.  The 
membrane was desalted, and DNAse was added to remove any remaining DNA from the sample.  
The RNA was washed and eluted in RNAse-free water. 
 
mRNA Purification 
 In order to isolate mRNA from the total RNA sample, the Promega PolyATract mRNA 
isolation system was used (cat no. Z5210).  1 mg of total RNA was brought to a volume of 500 
μl with water.  The solution was brought to 65˚C for 10 minutes, and then 3 μl of biotinylated-
oligo(dT) probe and 13 μl of 20X saline sodium citrate buffer (SSC) were added.  The solution 
was allowed to cool to room temperature.  Streptavidin MagneSphere Paramagnetic Particles 
(SA-PMP) were resuspended and washed with 0.5X SSC.  The tube containing the RNA was 
added to the SA-PMPs and incubated at room temperature for 10 minutes.  This mixture was 
placed in the magnetic stand to isolate the SA-PMPs bound to mRNA, and the supernatant was 
removed.  The remaining beads were washed with 0.1X SSC.  The final pellet was resuspended 
in 1 mL of water and moved to a clean RNAse-free tube. 
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Library PCR 
The purified mRNA was used to create a cDNA library with the Clontech Make Your 
Own "Mate & Plate" Library System (cat no. 630490).  A first strand cDNA synthesis was 
performed in duplicate using 750 ng of each mRNA sample, an oligo-dT primer to select for 
mRNA, and the SMART MMLV Reverse Transcriptase to create DNA from the RNA templates 
by incubation at 72˚C for 1 hour.  A provided mouse Poly A+ Liver RNA was used as a control 
to ensure the RNA was reverse-transcribed effectively.  After the PCR reaction had completed, 1 
μL of RNAse H was added to each tube to remove the RNA template.  This first strand cDNA 
was then amplified via LD-PCR with the Advantage 2 DNA Polymerase (cat no. 639207).  PCR 
conditions were as follows: 95˚C 30 seconds, 95˚C 10 seconds followed by 68˚C for 6 minutes, 
this last step was repeated for 24 cycles, with 5 seconds added to the 68˚C incubation each time, 
the reaction was then kept at 68˚C for 5 minutes.  Once this reaction reached completion, 7 μL of 
each sample and the control was run on a 1.2% agarose gel containing ethidium bromide.  This 
gel was viewed to ensure that the amplification process had been effective and that a wide range 
of fragment sizes were included in the library. 
 
Library Purification 
 The PCR-amplified Library cDNA was purified using a Clontech CHROMA SPIN +TE-
400 Column (cat no. 636076).  The samples were loaded into the column and centrifuged using a 
swinging bucket rotor at 700 g for 5 minutes.  The resulting liquid in the collection tube was 
pooled for the samples of the same type and 20 μL of 3M sodium acetate, 500 μL of ice cold 
99% ethanol, and 1 μL of GlycoBlue (Ambion) were added to the tube.  The samples were 
incubated at -80˚C for one hour, and then centrifuged at 4˚C at 14,000 rpm for 1 hour.  The 
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supernatant was removed and the pellets were air dried for 10 minutes before being resuspended 
in 20 μL of deionized water. 
 
Library Ligation 
 The cDNA library was then recombined into the pGADT7-Rec expression vector in vivo 
according to the Clontech Yeastmaker Yeast Transformation System 2 protocol (cat no. 630439).  
For this transformation, a frozen stock of yeast strain Y187 (cat no. 630457) was streaked on a 
YPDA media plate, and incubated for 3 days at 30˚C.  A single colony was removed from this 
plate and was incubated in 3 mL of liquid YPDA medium shaking at 250 rpm at 30˚C for 8 
hours.  5 μL of this culture was then transferred to 50 mL of YPDA, and the incubation 
continued with shaking until the OD600 reached 0.15.  The cells were pelleted at 700g for 5 min, 
and resuspended in 100 mL of fresh YPDA.  This suspension was incubated at 30˚C until the 
OD600 reached 0.4.  At this point the yeast were divided into two 50 mL tubes and pelleted at 
700g for 5 min.  The pellets were resuspended in 30 ml of sterile water and pelleted again.  This 
pellet was resuspended in 1.5 mL of 1.1x Tris-EDTA/Lithium Acetate (TE/LiAc).  This 
resuspended cell pellet was centrifuged at high speed and resuspended in 600 μL of 
1.1xTE/LiAc.  At this point, the yeast were competent for transformation. 
 For each library, 3 μg of pGADT7-Rec was added to 20 μL of cDNA and 20 μL of 
carrier DNA in a pre-chilled 15 mL tube.  600 μL of competent cells and 2.5 mL of Polyethylene 
Glycol/Lithium Acetate (PEG/LiAc) were added to the tube, and the mixture was incubated at 
30˚C for 45 minutes.  160 μL dimethyl sulfoxide (DMSO) was added and the sample was 
incubated at 42˚C for 20 minutes.  The cells were pelleted at 700 g for 5 minutes, and 
resuspended in 3 mL of YPD Plus Medium.  This suspension was incubated at 30˚C for 90 
minutes, then pelleted and resuspended in 15 mL of 0.9% (w/v) NaCl.  The entirety of this 
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suspension was spread using onto 150mm SD/-Leu plates in 100 μL aliquots, along with a 1/10 
and 1/100 dilution to calculate transformation efficiency. 
 
Library Harvesting 
 The library was incubated at 30˚C on the SD/-Leu plates for 4 days.  A freezing medium 
was prepared using YPDA medium and 25% Glycerol.  5 mL of freezing medium was added to 
each plate and spread using glass beads to detach the colonies.  The liquid was pooled in a sterile 
flask and divided into 1 mL aliquots which were stored a -80˚C. 
 
Bait Creation 
Plasmid Creation 
Both VACV and MVA forms of A51 were screened as bait plasmids in order to compare 
interactions.  The MVA form lacks the last 25 residues which have been replaced with 5 
different amino acids.  Clones with the correct sequence were cut from previously cloned vectors 
using NdeI and SalI.  The pGBKT7 vector was cut with the same enzymes.  The proper fragment 
was ligated into the vector using New England Biolabs Quick Ligase (cat no.M2200L).  The 
resulting plasmid was transformed into One Shot TOP10 E. coli.  These E. coli cells were grown 
overnight on 100mm agar plates containing kanamycin (50 μg/mL) to select for successful 
transformants.  Individual colonies were then incubated overnight in 3 mL of LB Media with 50 
μg/mL kanamycin.  Plasmid DNA was isolated using the Omega Biotek E.Z.N.A. Miniprep Kit I 
(cat no. D6945-02).  The resulting purified plasmid was sequenced to confirm that the protein 
sequence had no mutations and was in frame with the Myc tag within the vector. 
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Transformation 
The bait plasmid was transformed into the Y2HGold Yeast strain according to the 
Clontech Yeastmaker Yeast Transformation System 2 protocol (cat no. 630439).  The Y2HGold 
yeast cells were made competent in the same manner used for the library.  After being made 
competent, 50 μL of the competent cells were added to a pre-chilled sterile tube containing 5 μL 
of denatured carrier DNA and 100 ng of either the VACV A51 or MVA A51 containing 
pGBKT7 construct.  500 μL of PEG/LiAc was added to the tube, and the mixture was incubated 
at 30˚C for 30 minutes.  20 μL of DMSO was added, and the sample was incubated at 42˚C for 
15 minutes.  The cells were pelleted at high speed and resuspended in 1 mL of YPD Plus 
medium.  The cells were pelleted again and resuspended in 1 mL 0.9% (w/v) NaCl solution.  100 
μL aliquots were spread on SD/-Trp plates and incubated for 4 days at 30˚C. 
 
Testing for Expression, Self-Activation and Toxicity 
 All of the positive clones were gathered from the SD/-Trp plates and organized in a grid 
on an SD/-Trp plate.  These colonies were tested for self-activation and expression in order to 
choose the best candidates for the actual screen.  First, the colonies were replica-plated onto a 
SD/-Trp plate containing 125 ng/mL Aureobasidin A, a selection marker for a positive 
interaction between bait and prey plasmids.  The colonies were also tested for their ability to 
grow in the absence of Trp and Leu, a selection marker for diploid cells.  To test this, the 
colonies were replica plated onto an SD/-Leu/-Trp plate.  Finally, to test for activation of the 
lacZ gene, a marker for a positive interaction, the colonies were replica plated onto a 150mm 
sheet of filter paper and incubated overnight.  The filter paper was submerged in liquid nitrogen 
for 10 seconds and thawed before being placed into a 150 mm dish containing another sheet of 
filter paper, presoaked with 5 mL of Z buffer/X-gal solution containing Z buffer (Na2HPO4 • 
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7H2O 16.1 g/L, NaH2PO4 • H2O 5.50 g/L, KCl 0.75 g/L, MgSO4 • 7H2O 0.246 g/L) X-gal and 
2-mercaptoethanol.  This plate was incubated for 8 hours at 30˚C to see if any of the colonies 
would turn blue, an indicator for a positive interaction. 
 In order to test for expression and toxicity, the protein was isolated following the protocol 
documented by Zhang (Zhang et al., 2011).  The cells were treated with 2.0 M LiAc and 0.4 M 
NaOH for 5 min on ice.   This extract was boiled in SDS-PAGE sample buffer and analyzed via 
western blot, using an antibody for the Myc tag fused to the protein from the vector.  This 
verified that the protein was being expressed. 
 
Yeast Two-Hybrid Screen 
Yeast Mating 
 After choosing an acceptable colony for each of the desired bait proteins, that colony was 
incubated in 50 mL of SD/-Trp medium at 30˚C until the OD600 reached 0.8.  At this point cells 
were pelleted and resuspended in 5 mL of SD/-Trp media in a 2 L flask.  A 1 mL aliquot of the 
desired library was thawed and added to each bait culture, and 45 mL of 2x YPDA media with 
50 μg/mL of kanamycin was added.  These were incubated at 30˚C while shaking at the lowest 
possible speed for 24 hours.  After 24 hours the cultures were examined for the presence of 
zygotes.  If zygotes were present, no further incubation was needed and the cells were pelleted.  
The flask was rinsed twice with 50 mL of 0.5x YPDA, which was then used to resuspend the 
cells.  The cells were pelleted and resuspended in 10 mL of 0.5x YPDA with 50 μg/mL of 
kanamycin.  Controls were made by spreading 100 μL of 1/10, 1/100, 1/1,000 and 1/10,000 
dilutions of the culture on SD/-Trp, SD/-Leu and DDO plates.  The remainder of the culture was 
spread in 200 μL aliquots on DDO/A plates and incubated at 30˚C for 5 days. 
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Collection of Positive Colonies 
 Colonies that grew on the DDO/A plates were resuspended in sterile water and organized 
in a grid on single DDO/A plates.  These plates served as master plates to maintain the positive 
clones.  The suspension was also placed on TDO/A and QDO/A plates to filter out false 
interactions. 
 
Sequencing 
 Colonies that grew in the presence of every selection agent were sent for sequencing.  
Vectors were isolated from the positive colonies using the Clontech Easy Yeast Plasmid 
Isolation Kit (cat no. PT4073-1).  Colonies were resuspended in 500 μl of 10mM EDTA.  They 
were pelleted at 11,000 g for 1 minute and then resuspended in a buffer containing Zymolase.  
The solution was incubated at 30˚C for 1 hour.  It was then pelleted at 2000 g for 10 minutes.  
The supernatant was removed and the pellet was resuspended in 250 μl of a solution containing 
RNAse to remove RNA contamination.  They were then lysed using an SDS/alkaline lysis 
procedure for 5 minutes at RT.  The reaction was neutralized and pelleted at 11,000 g for 5 
minutes.  The supernatant was run through a column and eluted in 50 μl of sterile water.  The 
purified vector was amplified using TaKaRa ExTaq and the sequencing primers defined in the 
Clontech Make Your Own "Mate & Plate" Library System protocol.  The product was sent to 
Genewiz for purification. 
 
In-Fusion Cloning 
Primer Design 
 The A51 gene was cloned into the pGADT7-Rec to be used as a prey protein to allow 
detection of self-interaction.  Forward and reverse primers were designed for the VACV and 
 21 
MVA form of A51 according to the Clontech In-Fusion HD protocol.  Both used the same 
forward primer: TGGCCATTATGGCCCATGGACGGTGTCATCGTGTACTGC, which 
included 16 bp homology to the vector and 24 bp homology with the protein.  Additionally the 
reverse primer for VACV A51: 
GACATGTTTTTTCCCTTAGCGGGAAGCGATACCGTAGAC and MVA A51: 
GACATGTTTTTTCCCTTACAGCACCTTCCAGATACCAGC were designed following the 
same guidelines. 
 
Vector Ligation 
 VACV and MVA forms of A51 were amplified using the previously mentioned primers 
from a stock plasmid known to contain the correct VACV A51 sequence.  The PCR product was 
spin-column purified with the Qiagen QIAquick PCR Purification Kit (cat no. 28104).  200 ng of 
the purified PCR product was added to 200 ng of SmaI linearized pGADT7 vector in 2 μl of 5x 
In-Fusion HD Enzyme premix and then brought to 10 μl with deionized water.  This reaction was 
incubated at 50˚C for 15 minutes.  2.5 μl of the reaction was added to 50 μl of thawed Clontech 
Stellar Competent Cells (cat no. 636763) and kept on ice for 30 minutes.  The cells were heat 
shocked at 42˚C for 45 seconds and returned to the ice for 2 minutes.  500 μl of 37˚C SOC media 
was added to the cells, and they were incubated at 37˚C for one hour with shaking.  100 μL of 
the culture was plated onto LB media containing 50 mg/mL of kanamycin as a selection agent. 
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Vector Isolation 
 E. coli colonies containing pGADT7-Rec with the appropriate insert were placed into 3 
mL of LB media and incubated at 37˚C for 16 hours.  The plasmid was then isolated using the 
Omega Biotek E.Z.N.A. Plasmid Mini Kit I (cat no. D6945-02).  The resulting product was 
sequenced for accuracy before being transformed into yeast using the same protocol as the 
pGBKT7 plasmid. 
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Results 
 
Vesicular stomatitis virus (VSV) is capable of permissively infecting gypsy moth-derived 
Ld652 cells only if they are previously infected by vaccinia virus (VACV).  The sole factor 
responsible for this phenotype was previously determined by our lab to be poxvirus protein 
A51R (Mello lab, unpublished).  The mechanism of this rescue however, remained unknown.  It 
was hypothesized that A51 likely interacted with an endogenous host cell protein, as A51 alone 
is sufficient for the rescue.  In order to explore this option further in this project, a yeast two-
hybrid system was employed to identify potential host proteins that interact with VACV A51. 
 
Screen of A51R0 Self-Interaction 
Several yeast two-hybrid screens were performed to look for potential interactions.  The 
first screen tested A51 and MVA against themselves and each other for self-interaction.  Based 
on previous observations using a yeast two-hybrid screen of VACV proteins, it was predicted 
that A51 may interact with itself (McCraith et al., 2000), but the lack of VSV rescue by MVA 
led us to hypothesize that self-interaction was not occurring in this case.  For this two-hybrid 
screen, both the VACV and MVA form of A51 were cloned into the pGBKT7 and pGADT7-Rec 
vectors.  It was determined by immunoblotting that both the VACV and MVA forms of A51 
were expressed, although MVA expression was notably lower (data not shown).  These 
constructs were transformed into Y2HGold cells and Y187, respectively.  The strains were then 
mated against each other to test for self-interaction and plated on DDO/A plates. 
In order to test the resulting positives under more stringent conditions, 10 representative 
colonies from the A51/A51 and A51/MVA plates, along with the 4 positive interactions from the 
MVA/MVA plates were organized in a grid on plates with antibiotic lacking leucine, tryptophan, 
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histidine (TDO/A) and adenine (QDO/A).  These plates were grown for 3 days an observed 
again.  All colonies showed strong growth under the strongest selection (QDO/A), as seen in 
Figure 3, suggesting that self-interaction is occurring in all cases and thus not sufficient for the 
observed rescue of VSV. 
 
Figure 3: A51 Self-Interaction Screen on QDO/A 
10 colonies were chosen from original DDO/A plates for both A51/A51 and A51/MVA.  Only 4 colonies grew on 
the MVA/MVA DDO/A and all were moved to this plate.  All three combinations screened were able to grow on 
QDO/A suggesting a positive interaction between the proteins. 
 
Screen of A51R0 versus Ld652 Proteins 
In order to explore A51 interaction in cells where VSV rescue was observed, a cDNA 
library was created from Ld652 cells.  In order to ensure maximum purity, the total RNA was 
purified using poly-T magnetic beads to increase the concentration of mRNA present in the 
sample.  This was then amplified using oligo-dT primers to selectively convert mRNA to DNA.  
After another round of PCR, the sample was column purified to select for transcripts above 
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400bp in size.  This library was cloned into yeast strain Y187.  The mating for this screen was 
done as described previously, using verified Y2HGold colonies for both A51 and MVA. 
After plating the mated yeast on DDO/A, the yeast were incubated at 30˚C for 4 days.  At 
this point, there were an uncountable number of colonies on the DDO/A plates.  In order to 
determine if these colonies were indicative of real interactions or simply false positives as 
previously observed, 32 colonies of various sizes were chosen for both the A51 and MVA 
screens.  These colonies were organized in a grid on TDO/A and QDO/A plates and allowed to 
grow for 3 days.  At day 3, there were 11 A51 and 8 MVA colonies showing strong growth on 
QDO/A.  All 19 of these colonies were sequenced to determine which prey protein they 
contained.  Unfortunately, the sequencing was inconclusive. 
 
Screen of A51 versus Mouse Proteins 
The final screen examined A51 against a normalized mouse library to look for potential 
interactions with mammalian proteins.  The A51R gene was cloned into the pGBKT7 vector as 
previously described.  A single colony which was determined to be expressing the proper bait 
protein was grown overnight in selective media, then mated with 1 mL of the mouse library 
within yeast strain Y187.  Mating continued for approximately 24 hours until several zygotes 
were observed via microscopy.  The mated yeast was then plated onto DDO/A plates.   
172 positive interactions were taken from the DDO/A plates and were then transferred to 
TDO/A and QDO/A plates where they were grown for 3 days.  On day 3, there was no observed 
growth on the QDO/A plates, and approximately 60 colonies had shown strong growth on the 
TDO/A plates.  The pGADT7-Rec vector was isolated from these colonies and amplified via 
PCR.  The product was spin-column purified and analyzed via gel electrophoresis to determine 
whether amplification had occurred.  In all 57 cases where amplification had occurred, and 
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purification resulted in a DNA concentration above 20 ng/μl, the purified PCR product was 
sequenced.  Unfortunately, due to inherent difficulties in the yeast two-hybrid technology, every 
sequenced clone was determined to be a false positive. 
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Discussion 
 
 Using a yeast two-hybrid screen we showed that self-interaction of VACV-encoded 
protein A51 occurs as previously reported (McCraith et al., 2000), but the self-interaction is not 
sufficient for the rescue of VSV by VACV.   We also attempted to address the question of which 
proteins encoded by moth and mouse cDNA libraries interact with A51, but were unsuccessful 
due to difficulties with the two-hybrid technology.   
The primary difficulty in this project was the high occurrence of false positives in the 
yeast two-hybrid screen.  False positives were defined as colonies that were able to grow on 
either QDO/A or TDO/A plates and contained an out-of-frame prey sequence.  The number of 
out-of-frame sequences in the library is expected to be high due to the nature of cDNA synthesis.  
The cDNA is made from mRNA using an oligo-dT primer, thus all cDNA synthesis initiates at 
the 3’ end of the mRNA molecule; there is no defined stopping point for the polymerase in the 
PCR reaction, so termination may occur at any base within the transcript.  Because each codon 
consists of three nucleotides, termination at either the second or third nucleotide in the sequence 
will lead to an out-of-frame sequence once it is inserted into a vector.  Finally, as there is a 67% 
chance that termination will occur at the incorrect nucleotide, a high number of these out-of-
frame inserts should be expected.  The vector contains its own start codon for the insert, so 
transcription and translation can occur regardless of whether the insert is in frame or not.  Due to 
the high frequency of stop codons outside the normal reading frame, the out-of-frame inserts 
tend to result in the translation of short (2-100 residues) hydrophobic peptides that artificially 
“stick” to other proteins (Vidalain et al., 2004).  When these short peptides stick to the bait 
protein, they bring the fused activation domain in proximity to the beginning of the reporter 
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genes and activate transcription, thus allowing the yeast to grow on selective media without a 
genuine bait-prey interaction. 
 Although out-of-frame translation is an inherent issue in yeast two-hybrid screening, 
there are methods for reducing its occurrence.  In our observations, it was noted that once a 
sample was moved to a QDO/A plate, the number of false positives dropped dramatically (data 
not shown).  Ultimately, these out-of-frame transcripts could be removed from the library by 
using forward primers specific to each mRNA sequence, although the process to create such a 
vast array of primers would be time consuming and expensive. 
 To accurately determine which proteins (if any) interact with A51 within the cell, further 
research must be done. As A51 contains no discernible domains or motifs, other avenues should 
be pursued, such as in situ hybridization to investigate the possibility of A51 interacting with 
specific DNA or RNA sequences. 
Repeating the moth library screen is a necessity, and using TDO/A or QDO/A selection 
instead of DDO/A plates to originally grow the mated yeast may reduce the large number of 
colonies observed in this screen.  Reducing the number of positives would allow further 
screening and sequencing of each positive, thus eliminating the possibility of missing certain 
interactions which may have occurred in this experiment.    
The function of A51 remains a mystery, however, we hypothesize that uncovering its 
function will reveal further information about how poxviruses function and possibly uncover a 
novel domain or motif involved in its function.  Poxviruses remain a threat to the human 
population, and understanding how they cause disease is the first step in fighting back. 
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